Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Corp

IART

Get informed when a big investor buys or sells

+ Follow
Market Cap$926.27M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Integra Lifesciences Holdings CorpIntegra Lifesciences Holdings Corp71-1%0.61.9
$16.00

Target Price by Analysts

34.3% upsideIntegra Lifesciences Holdings Target Price DetailsTarget Price
$32.51

Current Fair Value

173% upside

Undervalued by 173% based on the discounted cash flow analysis.

Share Statistics

Market cap$926.27 Million
Enterprise Value$2.69 Billion
Dividend Yield$- (-)
Earnings per Share$-6.73
Beta1.21
Outstanding Shares78,577,000

Return

Return on Equity1.22%ROE
Return on Assets0.37%
Return on Invested Capital4.23%

Valuation & Multiples

P/E Ratio70.98P/E Ratio
PEG-18.94PEG
Price to Sales0.57Price to Sales
Price to Book Ratio0.92Price to Book Ratio
Enterprise Value to Revenue1.62
Enterprise Value to EBIT20.02
Enterprise Value to Net Income206
Total Debt to Enterprise0.75
Debt to Equity1.89Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
October 21, 2026
EPS Estimate
$0.56
Average shareholder expectation
Revenue Estimate
$413.16 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 29, 2026
EPS Estimate
$0.56
Average shareholder expectation
Revenue Estimate
$415.36 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.07%▼ 97.02%
Total Invested$812,174▼ 99.94%
Investors Holding13▼ 200.00%

ESG Score

No data

About Integra Lifesciences Holdings Corp

CEO: Peter Arduini